Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
1.050
-0.040 (-3.67%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Virax Biolabs Group Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Apr '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Market Capitalization
5211---
Market Cap Growth
44.87%-84.34%----
Enterprise Value
-2-46---
Last Close Price
1.050.726.95---
PS Ratio
33.0410.831262.87---
PB Ratio
0.530.331.21---
P/TBV Ratio
0.530.321.21---
EV/Sales Ratio
--701.38---
Debt / Equity Ratio
0.070.040.02--0.21-0.62
Asset Turnover
0.010.020.00-3.98-
Inventory Turnover
0.270.640.44---
Quick Ratio
10.6723.0110.350.020.020.02
Current Ratio
11.5825.9410.610.040.050.02
Return on Equity (ROE)
-90.64%-95.98%-141.63%---
Return on Assets (ROA)
-47.66%-49.90%-72.67%-2453.52%-1294.67%-
Return on Capital (ROIC)
-51.27%-52.89%-91.03%---
Earnings Yield
-144.34%-397.61%-50.48%---
FCF Yield
-115.80%-425.13%-38.66%---
Buyback Yield / Dilution
-50.43%-88.75%-11.15%-297.67%-130.43%-
Updated Nov 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q